| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/14/2009 | US7560490 Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof |
| 07/14/2009 | US7560442 For prophylaxis and therapy of diabetes mellitus Type I and Type II, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative diseases (Alzheimer's disease, Parkinson's disease), neuropathic diseases, neuropathic pain and polyneuropathy |
| 07/14/2009 | US7560440 Endothelial growth factors; antiischemic agents; neovascularization |
| 07/14/2009 | CA2403321C Amide compounds and use thereof |
| 07/14/2009 | CA2360776C Highly purified ethyl epa and other epa derivatives for psychiatric and neurological disorders |
| 07/09/2009 | WO2009086123A1 Imidazo [1,2-a] pyridine compounds |
| 07/09/2009 | WO2009085832A2 Manufacture of tablet |
| 07/09/2009 | WO2009085637A1 Amorphous metaxalone and amorphous dispersions thereof |
| 07/09/2009 | WO2009084975A1 Composition exhibiting high osmotic antimicrobial, anti-inflammatory and regeneration activity |
| 07/09/2009 | WO2009084695A1 2-aminoquinazoline derivative |
| 07/09/2009 | WO2009084671A1 Human anti-α9 integrin antibody |
| 07/09/2009 | WO2009083759A1 Oral pharmaceutical suspension comprising paracetamol and ibuprofen |
| 07/09/2009 | WO2009083608A1 Quinazolines and related heterocyclic compounds, and their therapeutic use |
| 07/09/2009 | WO2009083436A1 (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor |
| 07/09/2009 | WO2009083115A1 Pharmaceuticals and the production and use thereof in the treatment of painful neuropathies |
| 07/09/2009 | WO2009048940A3 Diacerein pharmaceutical formulations |
| 07/09/2009 | WO2009034029A3 1-substituted 4-heterocyclylpiperidines for use as cgrp antagonists |
| 07/09/2009 | WO2008154251A4 C3b antibodies and methods for the prevention and treatment of complement- associated disorders |
| 07/09/2009 | WO2008147864A3 Methods of using piperazine compounds in treating sodium channel-mediated diseases or conditions |
| 07/09/2009 | WO2008141511A8 A HUMAN ANTI-TNFα MONOCLONAL ANTIBODY AND THE USE THEREOF |
| 07/09/2009 | WO2008138889A8 3, 6-disubstituted-imidazo [1, 2-b] pyridazines and 3, 5-disubstituted pyrazolo[1, 5-a] pyrimidines as phosphatidylinositol-3-kinase inhibitors |
| 07/09/2009 | US20090176980 4-[4-Isopropoxy-5-(5-isopropyl-2-methyl-phenoxymethyl)-6-methyl-pyridin-2-yl]-5-isopropyl-1H-indazole; binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology |
| 07/09/2009 | US20090176880 Methods for Culturing Human Lung Mast Cells and Uses Thereof |
| 07/09/2009 | US20090176853 Adamantane derivatives |
| 07/09/2009 | US20090176845 adrenergic receptor agonists such as (8-Methoxy-1,2,3,4-tetrahydro-naphthalen-2-yl)-propyl-pyridin-4-ylmethyl-amine, used as analgesics, decongestants, antidepressants and anxiolytic agents or for the treatment of vision defects, neurodegenerative diseases, diarrhea, attention deficit disorder, psychoses |
| 07/09/2009 | US20090176837 Compounds with activity at retinoic acid receptors |
| 07/09/2009 | US20090176806 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-(2-chlorophenyl)-4-[1-(3-hydroxypropyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2,5-dione, used for treating cardiovascular, skin, nervous system disorders and immunological disorders, diabetes, inflammatory diseases and cancer |
| 07/09/2009 | US20090176799 Phosphodiesterase 4 inhibitors |
| 07/09/2009 | US20090176798 New compounds III |
| 07/09/2009 | US20090176773 Non-Peptidic Inhibitors of AKAP/PKA Interaction |
| 07/09/2009 | US20090176763 Azaindoles useful as inhibitors of JAK and other protein kinases |
| 07/09/2009 | US20090176750 Specified ratio of penetration enhancers to solvents and emulsifiers; fluocinolone |
| 07/09/2009 | US20090176713 Co-Administration of an Agent Linked to an Internalization Peptide with an Anti-Inflammatory |
| 07/09/2009 | US20090175935 Pharmaceutical compositions of duloxetine |
| 07/09/2009 | US20090175893 Albumin-Fused Anti-Angiogenesis Peptides |
| 07/09/2009 | US20090175881 Interleukin-17A specific immunoglobulin for use in prevention and treatment of inflammatory, autoimmune and proliferative disorders |
| 07/09/2009 | US20090175874 Novel interleukin-1 receptor intracellular ligand proteins and inhibitors of ligand binding |
| 07/09/2009 | US20090175860 Compositions and Methods of Use for Antibodies of c-Met |
| 07/09/2009 | CA2711272A1 Quinazolines and related heterocyclic compounds, and their therapeutic use |
| 07/09/2009 | CA2711211A1 Oral pharmaceutical suspension comprising paracetamol and ibuprofen |
| 07/09/2009 | CA2710452A1 Imidazo [1,2-a] pyridine compounds |
| 07/09/2009 | CA2710318A1 Drugs as well as their production and use in the treatment of pain-associated neuropathies |
| 07/09/2009 | CA2709709A1 Manufacture of tablet |
| 07/09/2009 | CA2707339A1 (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor |
| 07/09/2009 | CA2706566A1 Chromane derivatives as trpv3 modulators |
| 07/08/2009 | EP2077277A1 Use of mammalian cytokine; related reagents |
| 07/08/2009 | EP2077271A1 Macrolide derivative |
| 07/08/2009 | EP2077263A1 Quinazolines and related heterocyclic compounds and their therapeutic use |
| 07/08/2009 | EP2077120A2 Rheumatoid arthritis remedy containing il-6 antagonist as active ingredient |
| 07/08/2009 | EP2077114A1 Pharmaceutical preparation for treating fibromyalgia |
| 07/08/2009 | EP2076491A1 New benzamide derivatives as bradykinin antagonists |
| 07/08/2009 | EP1836173A4 Anti-inflammatory medicaments |
| 07/08/2009 | EP1635821B1 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl)amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
| 07/08/2009 | EP1539933A4 Methods of organ regeneration |
| 07/08/2009 | EP1511740B1 Phenyl-thiophene type vitamin d receptor modulators |
| 07/08/2009 | EP1495022B1 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
| 07/08/2009 | EP1435918B1 Highly compressible ethylcellulose for tableting |
| 07/08/2009 | EP1383927B1 New polynucleotides and polypeptides of the erythropoietin gene |
| 07/08/2009 | EP0738142B1 Perfluorocarbons as anti-inflammatory agents |
| 07/08/2009 | CN101475526A Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof |
| 07/08/2009 | CN100510073C Tryptase inhibitor |
| 07/08/2009 | CN100509846C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/08/2009 | CN100509811C Azaindoles |
| 07/08/2009 | CN100509810C Substituted beta-carbolines |
| 07/08/2009 | CN100509805C 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 07/08/2009 | CN100509782C NK* antagonists |
| 07/08/2009 | CN100509020C Plaster for bone disease |
| 07/08/2009 | CN100509008C Shutongfang for killing pain and preparation and use thereof |
| 07/08/2009 | CN100508978C Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 07/07/2009 | US7557222 1-[(4-Ethynylphenyl)]-2-[(phenyl)]-pyrrolidine-1,2-dicarboxamide derivatives as inhibitors of coagulation factors Xa and VIIa for the treatment of thrombosis |
| 07/07/2009 | US7557212 Tricyclic derivatives as LTD4 antagonists |
| 07/07/2009 | US7557210 Antiinflamamtory agents |
| 07/07/2009 | US7557194 Antibody materials for an IBD-associated polypeptide |
| 07/07/2009 | US7557139 Triptolide analogs for the treatment of autoimmune and inflammatory disorders |
| 07/07/2009 | US7557130 Bicyclic heteroaromatic alanines |
| 07/07/2009 | US7557128 Having antiallergic and anti-inflammatory effects while being devoid of the severe dose-limiting sedative side effects of ketotifen |
| 07/07/2009 | US7557106 inhibitors of FLT-3, Aurora-1, Aurora-2, and Aurora-3 protein kinases; leukemia; N-{4-[4-(5-Methyl-2H-pyrazol-3-ylmethyl)-6-(4-propyl-piperazin-1-yl)-pyrim- idin-2-ylsulfanyl]-phenyl}-propionamide |
| 07/07/2009 | US7557083 Gastrokines and derived peptides including inhibitors |
| 07/07/2009 | US7556827 Implantable active ingredient depot comprising matrix of glyceryl-monooleate and at least one modifier molecule comprising 1,2-distearoyl-glycerophosphatidyl-ethanolamin-methyl-polyethylene glycol wherein matrix provides controlled release of active ingredient |
| 07/07/2009 | CA2380128C Plasters containing 4-biphenylacetic acid |
| 07/07/2009 | CA2342628C The use of r-flurbiprofen for the treatment of inflammation |
| 07/02/2009 | WO2009082641A2 Compositions and methods for treating diseases associated with angiogenesis and inflammation |
| 07/02/2009 | WO2009082526A2 Ortho pyrrolidine, benzyl-substituted heterocycle ccr1 antagonists for autoimmune diseases & inflammation |
| 07/02/2009 | WO2009082514A1 Molecular targets for treatment of inflammation |
| 07/02/2009 | WO2009082347A1 Bis- (sulf onylamino) derivatives for use in therapy |
| 07/02/2009 | WO2009081222A1 Substituted tricyclic pyridine or pyrimidine vanilloid receptor ligands |
| 07/02/2009 | WO2009081219A1 Quinazoline derivatives as vanilloid receptor modulators |
| 07/02/2009 | WO2009080795A1 Efficient aspirin prodrugs |
| 07/02/2009 | WO2009080638A2 Sulfamides as zap-70 inhibitors |
| 07/02/2009 | WO2009079902A1 The preparation and use of a curcumin-zinc compound and its solid dispersion |
| 07/02/2009 | WO2009079693A1 Design and selection of medicaments that modulate the function and activity of interleukin 13 |
| 07/02/2009 | WO2009079692A1 Halogenated analogues of anti-fibrotic agents |
| 07/02/2009 | WO2009079683A1 Translocator protein ligands |
| 07/02/2009 | WO2009058944A3 Nonsteroidal compounds useful as modulators of glucocorticoid receptor ap-1 and /or nf- kappa b activity and use thereof |
| 07/02/2009 | WO2009010925A3 Annelated azaheterocyclic amides containing a pyrimidine fragment and method for the production and use thereof |
| 07/02/2009 | WO2008063943A4 Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain |
| 07/02/2009 | WO2007109045A8 Heterocyclic organic compounds for the treatment of in particular melanoma |
| 07/02/2009 | US20090171089 1,6 naphthridines useful as inhibitors of syk kinase |
| 07/02/2009 | US20090171086 2,4-pyrimidinediamine compounds and their uses |
| 07/02/2009 | US20090171085 N2,N4-bis(4-ethoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |